Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 Cell Model: Pharmaceutical and biopharmaceutical rationale for product standardization

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 11, 2010, Pages 6650-6659

  Gao, Song ^a   Jiang, Wen ^a   Yin, Taijun ^a   Hu, Ming ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Bioavailability; Caco 2 cell model; Dietary supplement; MRP; St. John's wort; Standardization

Indexed keywords

PHENOL DERIVATIVE; PLANT EXTRACT;

ARTICLE; BIOLOGICAL MODEL; CELL STRAIN CACO 2; CHEMISTRY; DIET SUPPLEMENTATION; DRUG EFFECT; HUMAN; HYPERICUM; INTESTINE; METABOLISM; QUALITY CONTROL; STANDARD; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; DIETARY SUPPLEMENTS; HUMANS; HYPERICUM; INTESTINES; MODELS, BIOLOGICAL; PHENOLS; PLANT EXTRACTS; QUALITY CONTROL; REFERENCE STANDARDS;

EID: 77953170400     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf904459u     Document Type: Article

References (32)

1. Smeets, R. J. A comparison of the relationship between depression, perceived disability, and physical performance in persons with chronic pain: a comment on Alschuler et al. (2008) Eur. J. Pain 2009, 13 (1) 109-110 (author reply 111-112)
2. Prager, L. M. Depression and suicide in children and adolescents Pediatr. Rev. 2009, 30 (6) 199-205 (quiz 206)
3. Hartley, S. L.; Maclean, W. E. Depression in adults with mild intellectual disability: role of stress, attributions, and coping Am. J. Intellect Dev. Disabil. 2009, 114 (3) 147-160
4. Keith, S. J.; Matthews, S. M. The value of psychiatric treatment: its efficacy in severe mental disorders Psychopharmacol. Bull. 1993, 29 (4) 427-430
5. Moller, H. J.; Volz, H. P. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities Drugs 1996, 52 (5) 625-638
6. Bilia, A. R.; Gallori, S.; Vincieri, F. F. St. John's wort and depression: efficacy, safety and tolerability - an update Life Sci. 2002, 70 (26) 3077-3096
7. Carmen Andreescu, B. H. M.; James, E. E. Complementary and alternative medicine in the treatment of bipolar disorder - a review of the evidence J. Affective Disorders 2008, 110, 16-26
8. Brattstrom, A. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression Phytomedicine 2009, 16 (4) 277-283
9. Barnes, J.; Anderson, L. A.; Phillipson, J. D. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties J. Pharm. Pharmacol. 2001, 53 (5) 583-600
10. Bent, S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center J. Gen. Intern. Med. 2008, 23 (6) 854-859
11. Zhou, S.; Chan, E.; Pan, S. Q.; Huang, M.; Lee, E. J. Pharmacokinetic interactions of drugs with St John's wort J. Psychopharmacol. 2004, 18 (2) 262-276
12. Schmidt, B.; Jaroszewski, J. W.; Bro, R.; Witt, M.; Staerk, D. Combining PARAFAC analysis of HPLC-PDA profiles and structural characterization using HPLC-PDA-SPE-NMR-MS experiments: commercial preparations of St. John's wort Anal. Chem. 2008, 80 (6) 1978-1987
13. Corti, G.; Maestrelli, F.; Cirri, M.; Zerrouk, N.; Mura, P. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability Eur. J. Pharm. Sci. 2006, 27 (4) 354-362
14. Paulke, A.; Noldner, M.; Schubert-Zsilavecz, M.; Wurglics, M. St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses Pharmazie 2008, 63 (4) 296-302
15. Butterweck, V.; Jurgenliemk, G.; Nahrstedt, A.; Winterhoff, H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test Planta Med. 2000, 66 (1) 3-6
16. Hu, M.; Chen, J.; Lin, H. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model J. Pharmacol. Exp. Ther. 2003, 307 (1) 314-321
17. Walle, T.; Walle, U. K. The β- d -glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2 Drug Metab. Dispos. 2003, 31 (11) 1288-1291
18. Walgren, R. A.; Lin, J. T.; Kinne, R. K.; Walle, T. Cellular uptake of dietary flavonoid quercetin 4'-β-glucoside by sodium-dependent glucose transporter SGLT1 J. Pharmacol. Exp. Ther. 2000, 294 (3) 837-843
19. Walgren, R. A.; Karnaky, K. J., Jr.; Lindenmayer, G. E.; Walle, T. Efflux of dietary flavonoid quercetin 4'-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2 J. Pharmacol. Exp. Ther. 2000, 294 (3) 830-836
20. Wolffram, S.; Block, M.; Ader, P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine J. Nutr. 2002, 132 (4) 630-635
21. Patanasethanont, D.; Nagai, J.; Matsuura, C.; Fukui, K.; Sutthanut, K.; Sripanidkulchai, B. O.; Yumoto, R.; Takano, M. Modulation of function of multidrug resistance associated-proteins by Kaempferia parviflora extracts and their components Eur. J. Pharmacol. 2007, 566 (1-3) 67-74
22. Tian, X.; Yang, X.; Wang, K. The efflux of flavonoids morin, isorhamnetin-3- O -rutinoside and diosmetin-7- O -β- d -xylopyranosyl-(1-6) -β- d -glucopyranoside in the human intestinal cell line Caco-2 Pharm. Res. 2006, 23 (8) 1721-1728
23. Kim, D. H.; Jung, E. A.; Sohng, I. S.; Han, J. A.; Kim, T. H.; Han, M. J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities Arch. Pharm. Res. 1998, 21 (1) 17-23
24. Parisis, D. M.; Pritchard, E. T. Activation of rutin by human oral bacterial isolates to the carcinogen-mutagen quercetin Arch. Oral Biol. 1983, 28 (7) 583-590
25. Zuo, Z.; Zhang, L.; Zhou, L.; Chang, Q.; Chow, M. Intestinal absorption of hawthorn flavonoids - in vitro, in situ and in vivo correlations Life Sci. 2006, 79 (26) 2455-2462
26. Serra, H.; Mendes, T.; Bronze, M. R.; Simplicio, A. L. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones Bioorg. Med. Chem. 2008, 16 (7) 4009-4018
27. Tourniaire, F.; Hassan, M.; Andre, M.; Ghiringhelli, O.; Alquier, C.; Amiot, M. J. Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells Mol. Nutr. Food Res. 2005, 49 (10) 957-962
28. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem. Biophys. Res. Commun. 1991, 175 (3) 880-885
29. Ang, C. Y.; Hu, L.; Heinze, T. M.; Cui, Y.; Freeman, J. P.; Kozak, K.; Luo, W.; Liu, F. F.; Mattia, A.; DiNovi, M. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage J. Agric. Food Chem. 2004, 52 (20) 6156-6164
30. Li, X. J.; Zhao, B. L.; Liu, G. T.; Xin, W. J. Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations Free Radical Biol. Med. 1990, 9 (2) 99-104
31. Ates, B.; Abraham, L.; Ercal, N. Antioxidant and free radical scavenging properties of N -acetylcysteine amide (NACA) and comparison with N -acetylcysteine (NAC) Free Radical Res. 2008, 42 (4) 372-377
32. Draves, A. H.; Walker, S. E. Analysis of the hypericin and pseudohypericin content of commercially available St John's wort preparations Can. J. Clin. Pharmacol. 2003, 10 (3) 114-118